Interestingly, UBR5 suppresses MYC-dependent priming to therapy-induced apoptosis in cancer cells as it resets MYC to levels that are not enough to induce apoptosis, whereas in normal cells accumulated MYC triggers apoptosis. This evidence concerns the gene UBR5 and cancer.